Mass Spectrometry-based Immune Profiling in Autoimmune Diseases

ConditionsSystemic Lupus Erthematosus Sjogren's Syndrome Inflammatory Myopathies Systemic Sclerosis (SSc)Vasculitis Rheumatoid Arthritis (RA)Ankylosing Spondylitis Osteoarthritis Gouty Arthritis (GA)Psoriatic Arthritis (PsA)Healthy Controls

Trial statusNot yet recruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorPeking University People's Hospital

About this trial

Based on mass spectrometry flow method, this study analyzed the typing of new T, B, NK and DC cell subsets in peripheral blood of common autoimmune diseases and their correlation with disease activity, aiming at establishing an early screening and diagnosis model of autoimmune diseases.

Eligibility criteria

Qualifiers

Male or female, and aged 18-70 at the time of screening interview (inclusive).

The diagnosis of each disease meets the following standards - Systemic lupus erythematosus: 1997 ACR lupus classification standard

Behcet's disease: 2014 ICBD Behcet's disease classification standard

ANCA-associated vasculitis: 1990 American College of Rheumatology Classification Standard

Disqualifiers

None

Trial design

Treatments tested in this trial

Not listed

Trial groups

500 Participants

are grouped into 1 trial group

Locations

This trial has no locations

Sponsors and collaborators

Peking University People's Hospital

Lead sponsor

National Natural Science Foundation of China

Collaborator

Zhejiang PuLuoTing Health Technology Co., Ltd.

Collaborator

Source ClinicalTrials.gov